Cognyxx Pharmaceuticals

Company Overview

Snapshot

Founded in June 2018 by Jacob George and Mike Fassler, Cognyxx Pharmaceuticals operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on research and development.

Business overview

Cognyxx Pharmaceuticals is a Health Tech & Life Sciences company specializing in the development of solutions for cardiovascular and neurodegenerative disorders. The company's core technology aims to empower the immune system to treat these conditions, serving the healthcare industry with a B2B business model. Its primary sector is Pharmaceuticals, with a focus on degenerative diseases, neuroscience, and cardiology.

Company Intelligence Q&A

When was Cognyxx Pharmaceuticals founded?

Cognyxx Pharmaceuticals was founded in June 2018.

Who are the co-founders of Cognyxx Pharmaceuticals?

The co-founders of Cognyxx Pharmaceuticals are Jacob George and Mike Fassler.

What is Cognyxx Pharmaceuticals' primary focus?

Cognyxx Pharmaceuticals focuses on developing treatments for cardiovascular and neurodegenerative disorders by empowering the immune system.

In which sector does Cognyxx Pharmaceuticals primarily operate?

Cognyxx Pharmaceuticals operates primarily in the Health Tech & Life Sciences sector, specifically within Pharmaceuticals.

What is the current funding stage of Cognyxx Pharmaceuticals?

Cognyxx Pharmaceuticals is currently in the Pre-Funding stage, indicating it is focused on early-stage development and seeking initial investment.